SMi Group reports: Key microbiology speaker interviews released ahead of SMi’s 4th Annual Microbiology West Coast Conference, taking place in two weeks.
SMi Group had the opportunity to speak with three featured expert microbiology speakers to discuss some of the difficulties presented in the industry and strategies that are implemented to overcome them. It’s imperative for microbiologists and leaders from all areas of pharmaceuticals, biologicals, cleanroom, microbiology and contamination industry experts to stay on top of the latest advancements, technologies and processes related to microbiology.
Industry experts will be gathering to represent top organisation and share their insights at the Pharmaceutical Microbiology West Coast event taking place on June 17th and 18th 2021, as a virtual conference with online access only.
Interested parties can register now at US$499 for pharmaceutical and biotechnology firms and US$999 for vendors and commercial firms at http://www.pharma-microbiology-usa.com/PJPR5
The following are excerpts from the three exclusive microbiology experts:
What is the greatest challenge for you to personally overcome within the pharmaceutical microbiology field currently?
“ATMPs force us to develop new CMC strategies and to re-evaluate well established micro concepts. The future of pharmaceutical microbiology lies in the close collaboration with process development and manufacturing. We have to be more than just a testing lab.”
Friedrich von Wintzingerode, QC Lead iNeST Project (Individualized Neoantigen Specific Therapy) Genentech, Inc.
The pharmaceutical microbiology industry has matured significantly in previous years, what key developments have you witnessed in the last year within the field?
I have seen a great focus on automation and digitization in recent years. There is increased collaboration in the industry to find flexible solutions to drive forward rapid microbial methods coupled with advanced data analysis and automation to get results faster and in turn, make decisions quicker.”
Lynn Johnson, Principal Scientist, Takeda
How would you like to see the pharmaceutical microbiology market develop in the future and where do you think the biggest growth area will be in the next few years?
“The biggest growth area in the next few years will be to move away from traditional compendial methods and implement real time methodology on the shop floor.”
Chrisitine Massaro, Director, Sterile & Microbiology Quality Assurance, Organon
Join industry experts to discuss the latest topics and pressing challenges in this field. The updated brochure is available on the conference website, visit http://www.pharma-microbiology-usa.com/PJPR5
The conference is sponsored by: Associates of Cape Cod, bioMérieux, Lonza, METTLER TOLEDO, and Microcoat
For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-online.co.uk
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk
SMi’s 4th Annual Pharmaceutical Microbiology West Coast Conference
Conference: June 17 – 18, 2021
Interactive Workshop: June 16, 2021
Virtual Conference: Online Access Only
http://www.pharma-microbiology-usa.com/PJPR5
#SMiPharmaMicroWC
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk.